Complex roles of myoglianin in regulating adult performance and lifespan by Augustin, Hrvoje et al.
This is an author produced version of Complex roles of myoglianin in regulating adult 
performance and lifespan.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/122887/
Article:
Augustin, Hrvoje, Adcott, Jennifer, Elliott, Christopher John Hazell 
orcid.org/0000-0002-5805-3645 et al. (1 more author) (2017) Complex roles of myoglianin 
in regulating adult performance and lifespan. Fly. ISSN 1933-6934 
https://doi.org/10.1080/19336934.2017.1369638
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
+$$6 *2'
' 1)&&  )'
 &)'#1'
)
		%%%)'
1'$'&6	)&'	.')$9'16)':.')$2
;81$(
7$&8<='- (1>8? 7@&#/

		
 !"!##$$$%&'%( ##)'*
+ !,-' """&
!' (&'-!
./01"-2'1&(2+-!%.%345&&"
6(-(	



 

!"#$%&'(
)
(*

(

+*,-.'
$#$#/#0$1223124"#$%$23132/
6)-(		

		
 !"#$ 
%
$&' #()($*+)'& ,-.
 '/0''1
&/2 0,
3$$/)'
4'
)")

&&
)- ' 
'$'

"#$ 
'$'
5#6()&$ .')$
&$-% 
7%$)
)&$ 
7%2  6)8
))
EXTRA VIEW
Complex roles of myoglianin in regulating adult performance and lifespan
Hrvoje Augustin a,b, Jennifer Adcott a,b, Christopher J. H. Elliott c, and Linda Partridge a,b
aInstitute of Healthy Ageing, and the Department of Genetics, Evolution, and Environment, University College London, Darwin Building, Gower
Street, London, UK; bMax Planck Institute for Biology of Ageing, Cologne, Germany; cDepartment of Biology, University of York, York, UK
ARTICLE HISTORY
Received 6 July 2017
Revised 15 August 2017
Accepted 16 August 2017
ABSTRACT
Myoglianin, the Drosophila homolog of the secreted vertebrate proteins Myostatin and GDF-11, is an
important regulator of neuronal modeling, and synapse function and morphology. While Myoglianin
suppression during development elicits positive effects on the neuromuscular system, genetic
manipulations of myoglianin expression levels have a varied effect on the outcome of performance
tests in aging ﬂies. Speciﬁcally, Myoglianin preserves jumping ability, has no effect on negative
geotaxis, and negatively regulates ﬂight performance in aging ﬂies. In addition, Myoglianin exhibits
a tissue-speciﬁc effect on longevity, with myoglianin upregulation in glial cells increasing the
median lifespan. These ﬁndings indicate complex role for this TGF-b-like protein in governing
neuromuscular signaling and consequent behavioral outputs and lifespan in adult ﬂies.
KEYWORDS
Drosophila; myoglianin;
lifespan; performance
Introduction
In vertebrates, growth differentiation factor 11 (GDF-
11) and Myostatin (MST, also known as GDF-8) are
closely related ligands of the Transforming growth
factor-b (TGF-b) superfamily of proteins. While MST
functions as a potent negative regulator of skeletal
muscle growth,1,2 GDF-11 is a well-documented sup-
pressor of neurogenesis and neuronal number.3-5 Both
proteins are detected in the blood serum and act pri-
marily by binding to activin type II receptors and elic-
iting response via intracellular transducers and
transcriptional modulators SMAD2 and SMAD3.6-9
Myoglianin (MYO) is the Drosophila homolog of
Myostatin and GDF-11, with strong expression
detected in muscle and glial cells.10,11
Recently, we identiﬁed MYO as a regulator of mus-
cle size and body weight in Drosophila larvae (Augustin
et al.12). In addition, genetic attenuation of myoglianin
(myo) in muscles or glial cells strengthens the synaptic
transmission and upregulates the density of critical pre-
and post-synaptic markers at the ﬂy NMJ (neuromus-
cular junction) via modulation of Smad2/Smox and
GSK-3/shaggy signaling (Fig. 1). The same manipula-
tion improves an electrical synapse output in adult ﬂies,
pointing toward a broader mechanism for synapse reg-
ulation.12 These ﬁndings led us to believe that Myoglia-
nin in ﬂies could combine some of the main roles of
MST and GDF-11 in vertebrates. Downregulation of
myo throughout development in either muscle or glial
compartment leads to improved larval motility (faster
crawling speed),12 demonstrating a way to enhance per-
formance parameters in ﬂies and, possibly, other spe-
cies. Interestingly, injections of human MST into
developing larvae reversed the positive affect of Myo-
glianin suppression on synaptic function, suggesting
the possibility of MST having a similar role in the
mammalian nervous system.
Both MST and GDF-11 have been implicated in the
control of age-related processes. For example, inhibi-
tion of Myostatin increases skeletal muscle mass and
strength and improves exercise-induced performance
outcome in aging mice.13,14 Myostatin levels decline
with age in healthy men,15 and MST inhibition is
being investigated as a potential treatment of
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sarcopenia and other muscle-wasting disorders.16
Conﬂicting results exist regarding the role of GDF-11
in aging. While early ﬁndings indicated a positive
effect of GDF-11 on brain17 and skeletal muscle18
aging, the subsequent reports identiﬁed GDF-11 as a
likely pro-aging factor.19-21
We therefore wanted to assess the impact of Myo-
glianin on age-dependent muscle function in adult
ﬂies. Myoglianin transcript is detected at low to mod-
erate levels in various ﬂy adult tissues.22 However, as
the muscular system in adult ﬂies appear to be
extremely limited in terms of its ability to grow and
regenerate,23 the role of MYO in aging ﬂies might be
signiﬁcantly different from its role in rapidly growing
tissues during development.
Results and discussion
In ﬂies with MYO levels reduced in muscles (using the
UAS-miRNAmyo construct driven by the Mef2-GAL4
driver), we observed improved ﬂight ability through-
out adult life compared with controls, with a small
decrease in body weight measured in these ﬂies with
age (Fig. 2A). These results parallel the improved
motility of 3rd instar larvae with genetically silenced
myo.12 Equally, the opposite effect on the ﬂight ability
was seen in myo-overexpressing ﬂies (Mef2-GAL4/
UAS-myoglianin, Fig. 2B).
In disagreement with a recent paper reporting
impaired climbing in the ﬂies with RNAi-reduced
myo expression in muscles,24 we saw no effect on the
climbing ability upon muscle-speciﬁc myo silencing
(Fig. 3A). Interestingly, increased myo expression pre-
vented age-related decline in the jumping ability,
resulting in ‘youthful’ jump test outcomes even in late
adulthood (day 48) (Fig. 3B).
Demontis et al.24 reported lifespan extension in
myo-overexpressing ﬂies and reduced longevity in
myo-silenced animals. In our hands, variable myo
expression levels in the muscle did not signiﬁcantly
affect lifespan (Fig. 4A). It is possible that these phe-
notypic differences stem from different muscle drivers
and RNAi constructs used to manipulate myoglianin
levels in adult muscles. For example, while the MHC-
GAL4 driver (used by Demontis et al., 201424) drives
strongly in thoracic muscles, the Mef2-GAL4 drives
“far more extensively, in most somatic musculature”.25
Intriguingly, myo overexpression in glial cells, previ-
ously shown to have a negative impact on the weight,
motility and synaptic parameters in Drosophila lar-
vae,12 resulted in signiﬁcantly increased median
lifespan, with glial silencing of myo having the oppo-
site effect (Fig. 4B). These ﬁndings further our
Figure 1. Reduced Myoglianin levels promote membrane targeting of the presynaptic active zone assembly regulator (Brp) and postsyn-
aptic glutamate receptors (type A) via inhibition of Smad2/ Smox and stimulation of GSK-3/shaggy signaling, resulting in enhanced
electrophysiological response.
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understanding of the lifespan-modulating role of the
glial compartment in Drosophila.26,27
Our results imply a complex role for Myoglianin in
modulating neuromuscular system function in adult
ﬂies, with different muscles/tissues requiring different
levels of MYO for achieving optimal functional output.
Furthermore, the combinatorial effect of these inputs is
likely to play an important role in determining the
overall health- and life-span in aging ﬂies. Overall, in
addition to its role as an important regulator of muscle
size, body weight, motility, and synaptic composition
and function in larvae,12 Myoglianin appears to have a
highly regulated and context-dependent impact on
adult tissues and whole organism in D. melanogaster.
Materials and methods
Fly stocks and husbandry
Tissue- and cell type-speciﬁc expression was achieved
with the GAL4-UAS system.28 To standardize genetic
background, parental GAL4 and UAS strains used to
generate experimental and control genotypes were
backcrossed to laboratory control strain wDah for at
least 6 generations. All stocks were maintained and all
experiments were conducted at 25C on a 12h:12h
light:dark cycle at constant humidity using standard
sugar/yeast/agar (SYA) medium29 (the food contained
5% sucrose (w/v), 1.5% agar (w/v), 0.3% propionic acid
(v/v), 0.3% nipagen (w/v) and either 1% (0.1 £ yeast),
5% (0.5 £ yeast), 10% autolysed brewer’s yeast (w/v)
and was prepared as described previously.30 UAS-miR-
NAmyo line11 was a gift from T. Awasaki and from the
T. Lee laboratory at Janelia Farm; UAS-myoglianin (2nd
chromosome) was a kind gift from M. O’Connor, Uni-
versity of Minnesota; Mef2-GAL4 (#27390) and repo-
GAL4 (#7415) were obtained from the Bloomington
Stock Center. wDah was the “wild-type” strain used in
all experiments. The white Dahomey (wDah) stock was
derived by incorporation of the w1118 mutation into the
outbred Dahomey background by backcrossing.
Flies were mated for 48 h before separating
females from males. Only female ﬂies were used in
the experiments.
Flight and climbing tests
Flight testing was done using a described previously
protocol.31 Individual ﬂies were released from the bot-
tom of a perspex (‘Sparrow’) box 40 cm high with a
light source at the top, and scored for ﬂight as follows:
top (2 points), middle (1 point) or bottom (no points).
The mean point achieved by 3–6 ﬂies was determined;
the procedure was repeated 5–10 and mean calculated
for each genotype/time point.
For the climbing (negative geotaxis) test, adult female
ﬂies were housed at 15 ﬂies/vial and 3 populations were
tested for each genotype/experiment. The ﬂies were
assayed at 5 time points (days 4, 18, 32, 46 and 70) for
climbing activity in a modiﬁed 25 ml ‘stripette’ tube.
The ﬂies were gently tapped to the base of the climbing
tube and their climbing progress was recorded after
45 s. Each population of ﬂies were assessed 3 times per
assay and the average values were used to calculate the
performance index as described previously.32
Figure 2. MYO negatively regulates ﬂight performance in adult
ﬂies. (A) Left: Flight performance index measured in Mef2-GAL4/
UAS-miRNAmyo (black) and control (red) ﬂies throughout the
adult life (n D 31–33, ANOVA genotype/age interaction
P D 0.0055). Right: Total wet weight of individual ﬂies measured
in young (day 5) and old (day 50) animals (n D 10–12). (B) Left:
Flight performance index measured in Mef2-GAL4/UAS-myoglia-
nin (black) and control (red) ﬂies (n D 26–29). The genotype/age
interaction was signiﬁcant (PD0.0056). Right: Total wet weight of
individual ﬂies measured in young (day 5) and old (day 50) ani-
mals (n D 10–12).
FLY 3
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 Y
or
k]
 at
 06
:49
 19
 O
cto
be
r 2
01
7 
Lifespan experiments
Flies in lifespan experiments were performed as described
previously.33Animals were reared at standard larval den-
sity and eclosing adults were collected over a 12 h period.
Females were mated for 48 h before being separated from
the males. Flies were maintained in vials on standard
SYA medium at a density of 10 ﬂies per vial and trans-
ferred to new vials every 2–3 d and scored for deaths.
Jump muscle performance
Jump muscle performance was determined using a min-
iature ergometer.34,35 Brieﬂy, ﬂies were anaesthetized
Figure 3. MYO affects jumping ability, but not climbing performance. (A) The climbing ability (‘negative geotaxis’) of the adult ﬂies of
denoted genotypes. No signiﬁcant difference between the genotypes was observed. (B) Jump muscle performance is sustained by
expression of myoglianin by Mef2 (n D 6–19 per genotype/age). In the full data set, including Mef2-GAL4/UAS-myoglianin, ANOVA
genotype interaction with age PD0.042; but without the 48 day-old data, or the Mef2-GAL4/UAS-myoglianin data the genotype-age
interaction is not signiﬁcant (P D 0.57 and P D 0.49, respectively).
Figure 4. Myoglianin in glia, but not in muscle, affects lifespan. (A) Lifespans in ﬂies expressing various myo transgenes in the muscle.
Median survival times for female ﬂies (in days) were 82 (Mef2-GAL4/UAS-miRNAmyo), 82 (Mef2-GAL4/UAS-myoglianin), 71 (C/UAS-myo-
glianin), 78 (C/UAS-miRNAmyo) and 76 (C/Mef2-GAL4); (B) The survival curves from ﬂies expressing myo constructs driven by the glial
repo-GAL4 driver. Median survival times for female ﬂies were 59 (repo-GAL4/UAS-miRNAmyo), 80 d (repo-GAL4/UAS-myoglianin), 67
(C/UAS-myoglianin), 73 (C/UAS-miRNAmyo) and 73 d (C/repo-GAL4).
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with CO2 and mounted on a tungsten pin and allowed
to recover for over 20 min. They were mounted in the
apparatus and the jump elicited by electrical stimulation
between the eyes. The jump response was determined
optically from the movement of the platform below the
ﬂy. For each ﬂy the biggest response to 4–10 stimuli
was determined. The best response of each ﬂy was used
in the calculation of mean and SEM and in statistical
evaluations. The experimenter was blind to the exact
genotypes during testing.
Statistical Analyses
Statistical analyses were performed using GraphPad
Prism 5 software (GraphPad Software Inc., USA). A 2
way ANOVA test was used to perform (age x geno-
type) interaction calculations. For other comparisons
between 2 or more groups, a one-way ANOVA
followed by a Tukey-Kramer post hoc test was used.
In all instances, P < 0.05 is considered to be statisti-
cally signiﬁcant (P < 0.05; P < 0.01; P < 0.001).
Log-rank tests were performed for survival. Values are
reported as the mean § SEM.
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